AlphaMaven AlphaMaven

AIFMD II Roundup: Key Reforms, EU Implementation and the UK Alternative

Reported by Jdsupra ·Skadden
Apr 15, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • EU member states face a 16 April 2026 deadline to transpose AIFMD II into national law, introducing stricter rules for loan origination, delegation, and liquidity management across all alternative investment fund managers.
  • • The European Commission delayed adoption of nonessential Level 2 regulatory measures until after 1 October 2027, creating risk of inconsistent rule application and regulatory divergence across EU jurisdictions as national authorities interpret requirements independently.
  • • EU AIFMs must immediately ensure compliance with stricter loan and liquidity rules while monitoring potential "gold-plating" at national levels during the extended Level 2 implementation period.
  • • The UK is pursuing an independent regulatory path outside AIFMD II, with proposed changes to its alternative investment fund manager framework currently under consultation, with responses expected in the first half of 2026.
  • • Regulatory divergence between EU and UK frameworks represents a structural shift for cross-border alternative investment operations, requiring managers to track both regimes independently rather than relying on harmonized EU standards.
Summary
The Alternative Investment Fund Managers Directive II (AIFMD II) introduces a comprehensive overhaul of EU regulations for alternative investment funds and their managers. The directive came into force on 15 April 2024, with EU member states required to transpose AIFMD II into national law by 16 April 2026—the deadline now active. The revised framework strengthens oversight of loan origination practices, delegation arrangements, and liquidity management protocols across all EU jurisdictions, reflecting heightened regulatory focus on systemic risk in the alternative asset management sector.

However, implementation faces a significant complication. In October 2025, the European Commission announced a delay in adopting nonessential Level 2 regulatory measures, pushing that timeline to after 1 October 2027. This creates a two-tier implementation structure where core substantive rules take effect immediately while technical and detailed regulatory guidance remains pending for 18 months. The delay introduces material operational uncertainty: without finalized Level 2 measures, national regulators will interpret AIFMD II requirements independently, creating potential for inconsistent application across EU member states and regulatory divergence that could fragment the single market for alternative asset management.

EU-based AIFMs face dual compliance obligations. Immediate action is required to ensure alignment with stricter provisions on loans and liquidity as each member state transposes them into law. Simultaneously, managers must monitor developments on Level 2 measures and remain alert to the risk of "gold-plating"—where individual EU nations impose more stringent requirements than the minimum EU standard—further fragmenting the regulatory landscape.

In parallel, the UK is charting a divergent regulatory course. No longer bound by EU directives post-Brexit, the UK is conducting its own consultation on proposed changes to its alternative investment fund manager framework. This represents a fundamental structural shift: rather than following harmonized EU standards, UK AIFMs will operate under an independent regime. Responses to the UK consultation are expected in the first half of 2026, potentially introducing another regulatory framework for cross-border managers to navigate.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

2 outlets

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Jdsupra AIFMD II Roundup: Key Reforms, EU Implementation and the UK Alternative Skadden AIFMD II Roundup: Key Reforms, EU Implementation and the UK Alternative